Skip to content


Open Access

Creating a nationwide cancer registration system to support AIDS-cancer match studies in Nigeria

  • Clement Adebamowo1Email author,
  • Elima Jedy-Agba1,
  • Emmanuel Oga1,
  • Peju Osinubi1,
  • Festus Igbinoba1,
  • Gloria Osubor1,
  • Theresa Otu1,
  • Henry Kumai1,
  • Michael Okobia1,
  • Prince Ejiroghene1,
  • Ahmed Mayun1,
  • James Abdulazeez1,
  • O Erinomo1,
  • Adebayo Ojo1,
  • Cornelius Uka1 and
  • Gloria Oyeoka1
Infectious Agents and Cancer20127(Suppl 1):P3

Published: 19 April 2012


Breast CancerCervical CancerSarcomaAdditional DataCancer Registry


Cancer registration started in Nigeria in 1962 but after a very promising start, the momentum was lost [1, 2]. Since 2009, Nigerian Health Ministry, IARC and IPRI, have given training, troubleshooting and mentoring.

Material and methods

20 cancer registries were trained and 5 have met criteria for population based cancer registries. Data for 2009 are presented in this report.


The commonest cancer at all sites is Prostate in men and Breast in women. There was a gradient in the incidence that paralleled the socio-economic development of the regions of the Country. The ASR for breast cancer ranged from 101.1 in Abuja to 7.5 in less cosmopolitan areas. For Prostate the ASR ranged from 73 in Abuja to 1.7. The other common cancers were Kaposi Sarcoma and Colo-Rectal in men, and cervix in women. Additional data collection and analysis is ongoing.


This study showed that breast and cervical cancer are the commonest in women while prostate is the commonest cancer in men.

Authors’ Affiliations

Nigerian National Cancer Registry System, Nigeria


  1. Parkin DM, Ferlay J, Hamdi-Cherif M, Sitas F, Thomas JO, Wabinga H, Whelan SL: Cancer in Africa: Epidemiology and Prevention. 2003, Lyon: IARC PressGoogle Scholar
  2. Solanke TF, Adebamowo AC: Report of the Workshop on the State of the Art in Oncology in Ibadan and Ife. 1998, Ibadan: National Headquarters of Cancer Registries in NigeriaGoogle Scholar


© Adebamowo et al; licensee BioMed Central Ltd. 2012

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.